Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy.

Main|Search|PHGKB






Last Posted: Jul 19, 2018

---

• Cancer Scientists Have Ignored African DNA in the Search for Cures  
  J Wapner, Newsweek, July 2018
• Genome-wide studies of heart failure and endophenotypes: lessons learned and future directions.  
  van der Ende Maaike Yldau et al. Cardiovascular research 2018 Jul 114(9) 1209-1225
• Cardiovascular risk in patients with familial hypercholesterolemia using optimal lipid-lowering therapy.  
  Galema-Boers Annette M et al. Journal of clinical lipidology 12(2) 409-416
• Genetic and Lifestyle Risks for CVD and Diabetes  
  ACC, July 4, 2018
• Comprehensive genetic testing in children with a clinical diagnosis of ARPKD identifies phenocopies.  
  Szabó Tamás et al. Pediatric nephrology (Berlin, Germany) 2018 Jun
• Genetic screening for Bartter syndrome and Gitelman syndrome pathogenic genes among individuals with hypertension and hypokalemia.  
  Bao Minghui et al. Clinical and experimental hypertension (New York, N.Y. : 1993) 2018 Jun 1-8
• Routine DNA tests will put NHS at the 'forefront of medicine'  
  I Sample, The Guardian, July 3, 2018
• Associations of Combined Genetic and Lifestyle Risks With Incident Cardiovascular Disease and Diabetes in the UK Biobank Study.  
  Said M Abdullah, et al. JAMA cardiology 2018 6 0.
• Pharmacogenomic studies of hypertension: paving the way for personalized antihypertensive treatment.  
  Eadon Michael T et al. Expert review of precision medicine and drug development 2018 3(1) 33-47
• Precision medicine for multiple sclerosis promotes preventative medicine.  
  Hansen Madison R et al. Annals of the New York Academy of Sciences 2018 May 1420(1) 62-71

more